La Roche-Posay Effaclar A.Z. Acne Treatment Gel 1.35 oz — Azelaic & 1.2% Salicylic Acid, Lightweight Hydrating

Effaclar A.Z. Gel is a fast-absorbing face gel that combines azelaic acid and 1.2% salicylic acid to treat recurring acne, reduce post-acne marks, and help improve visible signs of aging.

La Roche-Posay formulated this lightweight, hydrating gel to deliver targeted acne control while addressing texture, discoloration, and early fine lines. The dual-action formula penetrates pores to help clear and prevent blemishes, while azelaic acid works on dark spots and uneven tone. Allergy-tested and non-comedogenic, the gel is designed for daily use in routines for skin prone to breakouts and sensitivity.

How does this gel tackle both active breakouts and post-acne marks?

The combination of 1.2% salicylic acid and azelaic acid offers complementary actions: salicylic acid exfoliates inside the pore to reduce blocked oil and inflammation, while azelaic acid targets pigment and texture left after lesions heal. Used consistently, this approach helps clear current blemishes and fade discoloration from past breakouts.

• 1.2% salicylic acid: gentle pore exfoliation and oil control
• Azelaic acid: helps reduce dark spots and evens skin tone
• Non-comedogenic formula: minimizes risk of new pore blockages
• Fast absorption: leaves a non-greasy finish for layering

Will the gel help with early signs of aging like fine lines or loss of firmness?

While formulated primarily for acne-prone skin, Effaclar A.Z. Gel includes ingredients that support smoother texture and improved tone, which can make fine lines appear less noticeable. Regular use helps refine skin surface and may enhance firmness appearance without heavy creams that can clog pores.

• Smoother skin texture reduces visible fine lines
• Hydrating gel-creme base supports elasticity without greasiness
• Lightweight finish allows daytime layering under sunscreen and makeup

How should I incorporate Effaclar A.Z. Gel into my skincare routine?

Apply a thin layer to clean, dry skin once or twice daily depending on tolerance, avoiding the immediate eye area. Start with evening use or alternate days if you have sensitive skin, then increase frequency as tolerated. Follow with a moisturizer and, in the morning, a broad-spectrum sunscreen.

• Step 1: Cleanse and pat skin dry
• Step 2: Apply a pea-sized amount to affected areas
• Step 3: Layer a moisturizer and SPF during daytime
• Tip: introduce slowly if new to active acids

Is Effaclar A.Z. Gel suitable for sensitive or all skin tones?

The formula is allergy-tested and non-comedogenic, designed to be compatible with sensitive, acne-prone skin and effective across skin tones. As with any active product, patch testing and gradual introduction reduce the chance of irritation, and pairing with a barrier-supporting moisturizer can help maintain comfort.

• Allergy-tested for compatibility with sensitive skin
• Non-comedogenic to prevent pore congestion
• Works to fade pigment across a range of skin tones
• Patch test recommended for very reactive skin

Who is this for: Effaclar A.Z. Gel is aimed at people with recurring or stubborn acne who also want to address post-acne marks, uneven texture, and early signs of aging without heavy products. It suits those seeking a lightweight, dermatologist-developed treatment that can be added to established morning or evening routines, particularly if you prefer gel-textures and require a non-greasy option compatible with sensitive skin.

Ingredients

2039154 34 - INGREDIENTS: WATER • AZELAIC ACID • C15-19 ALKANE • GLYCERIN • TRIETHYL CITRATE • DIGLYCERIN • PANTHENOL • SILICA • AMMONIUM POLYACRYLOYLDIMETHYL TAURATE • TARAXACUM OFFICINALE (DANDELION) RHIZOME/ROOT EXTRACT • ZINC GLUCONATE • GLYCERYL STEARATE • PEG-100 STEARATE • SODIUM HYALURONATE • SODIUM HYDROXIDE • SODIUM PHOSPHATE • DISODIUM PHOSPHATE • HYDROXYETHYLCELLULOSE • HYDROXYPROPYL STARCH PHOSPHATE • TETRASODIUM GLUTAMATE DIACETATE • CITRIC ACID • TRISODIUM ETHYLENEDIAMINE DISUCCINATE • PENTYLENE GLYCOL • POLYSORBATE 60 • FRAGRANCE (F.I.L. V70048867/1).